New Weight-Loss, Diabetes Drugs Reach One in Eight Americans
(Bloomberg) -- One in eight US adults has tried medications from the fast-growing class of new diabetes and obesity drugs that includes Ozempic and Zepbound, underscoring how quickly the treatments have gained popularity. Of those who’ve tried the drugs, …